Earnings History Data for Esperion Therapeutics (ESPR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Esperion Therapeutics

Esperion Therapeutics, Inc. is a biopharmaceutical company. It focused on the research, development and commercialization of therapies for low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperion Therapeutics, Inc. is based in Plymouth, Michigan.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-05-2024	PM		ESPR	Esperion Therapeutics	390.00	N/A	-0.17	0.00	Esperion Therapeutics beats top-line and bottom-line estimates; reaffirms FY24 outlook [5/7/2024 6:04 AM]	2.40	0.28 (13.21%)	2.35	0.23 (10.85%)	0.70 - 3.40	33,833,027	4,460,000	11,236,442
Esperion Therapeutics beats top-line and bottom-line estimates; reaffirms FY24 outlook [5/7/2024 6:04 AM] Esperion Therapeutics Q1 2024 Earnings Preview [5/6/2024 10:34 AM]
27-02-2024	PM		ESPR	Esperion Therapeutics, Inc.	296.80	-0.50	-0.53	-0.76	Esperion Therapeutics GAAP EPS of -$0.50 misses by $0.02, revenue of $32.25M beats by $3.55M [2/27/2024 6:04 AM]	2.90	0.27 (10.27%)	2.64	0.01 (0.38%)	0.70 - 6.74	9,530,485	3,940,000	131,951
Esperion Therapeutics Q4 2023 Earnings Preview [2/26/2024 11:14 AM] Esperion Therapeutics GAAP EPS of -$0.50 misses by $0.02, revenue of $32.25M beats by $3.55M [2/27/2024 6:04 AM]
07-11-2023	PM		ESPR	Esperion Therapeutics, Inc.	110.20	-0.37	-0.42	-0.81	Esperion Therapeutics GAAP EPS of -$0.37 beats by $0.06, revenue of $34M beats by $3.85M [11/7/2023 6:03 AM]	1.02	0.06 (6.69%)	1.06	0.10 (10.85%)	0.70 - 8.87	2,523,150	2,840,000	243,030
Esperion Therapeutics Q3 2023 Earnings Preview [11/6/2023 3:15 PM] Esperion Therapeutics GAAP EPS of -$0.37 beats by $0.06, revenue of $34M beats by $3.85M [11/7/2023 6:03 AM]
01-08-2023	PM		ESPR	Esperion Therapeutics, Inc.	144.91	-0.46	-0.63	-1.05	Esperion Therapeutics GAAP EPS of -$0.46 beats by $0.15, revenue of $25.79M beats by $1.15M [8/1/2023 6:04 AM]	1.71	0.14 (8.92%)	1.66	0.09 (5.73%)	1.12 - 8.87	8,162,549	1,990,000	74,633
Esperion Therapeutics Q2 2023 Earnings Preview [7/31/2023 1:07 PM] Esperion Therapeutics GAAP EPS of -$0.46 beats by $0.15, revenue of $25.79M beats by $1.15M [8/1/2023 6:04 AM]
09-05-2023	PM	7:00 AM ET (May 9)	ESPR	Esperion Therapeutics, Inc.	124.70	-0.79	-0.65	-0.93	Esperion Therapeutics GAAP EPS of -$0.79 misses by $0.14, revenue of $24.33M beats by $2.36M [5/9/2023 7:03 AM]	1.42	0.07 (5.19%)	1.43	0.08 (5.93%)	1.12 - 8.87	2,186,887	1,940,000	17,395
Esperion Therapeutics GAAP EPS of -$0.79 misses by $0.14, revenue of $24.33M beats by $2.36M [5/9/2023 7:03 AM]
21-02-2023	PM	7:00 AM ET (Feb 21)	ESPR	Esperion Therapeutics, Inc.	414.78	-0.76	-0.87	-1.77	Esperion Therapeutics GAAP EPS of -$0.76 beats by $0.09, revenue of $18.8M misses by $1.8M [2/21/2023 7:01 AM]	5.61	-0.31 (-5.32%)	5.87	-0.05 (-0.84%)	3.81 - 8.87	2,928,547	1,220,000	17,112
Esperion Therapeutics Q4 2022 Earnings Preview [2/20/2023 10:25 AM] Esperion Therapeutics GAAP EPS of -$0.76 beats by $0.09, revenue of $18.8M misses by $1.8M [2/21/2023 7:01 AM]
01-11-2022	PM	7:00 AM ET (Nov 1)	ESPR	Esperion Therapeutics, Inc.	531.75	-0.81	-0.93	-2.62	Esperion Therapeutics GAAP EPS of -$0.81 beats by $0.12, revenue of $19M misses by $0.68M [11/1/2022 7:06 AM]	8.27	0.14 (1.73%)	8.40	0.27 (3.32%)	3.28 - 10.83	1,937,306	1,070,000	981
Esperion Therapeutics Q3 2022 Earnings Preview [10/31/2022 1:47 PM] Esperion Therapeutics GAAP EPS of -$0.81 beats by $0.12, revenue of $19M misses by $0.68M [11/1/2022 7:06 AM] Esperion Reports Third Quarter 2022 Financial Results and Provides Company Update [Nov-01-22 07:00AM]
02-08-2022	PM	7:00 AM ET (Aug 2)	ESPR	Esperion Therapeutics, Inc.	391.27	-1.05	-0.95	-1.67	Esperion Therapeutics GAAP EPS of -$1.05 misses by $0.13, revenue of $18.84M beats by $0.22M [8/2/2022 7:05 AM]	5.86	0.41 (7.52%)	5.53	0.08 (1.47%)	3.28 - 15.89	796,405	660,000	5,046
Esperion Therapeutics Q2 2022 Earnings Preview [8/1/2022 1:11 PM] Esperion Therapeutics GAAP EPS of -$1.05 misses by $0.13, revenue of $18.84M beats by $0.22M [8/2/2022 7:05 AM] Esperion stock rises as Q2 product revenue grows 28% Y/Y [8/2/2022 11:45 AM] Esperion Reports Second Quarter 2022 Financial Results and Provides Company Update [Aug-02-22 07:00AM]
03-05-2022	PM	7:00 AM ET (May 3)	ESPR	Esperion Therapeutics	347.00	-0.93	-0.96	0.00	Esperion Therapeutics GAAP EPS of -$0.93 beats by $0.11, revenue of $18.83M beats by $3.42M [5/3/2022 7:13 AM]	6.53	0.80 (13.87%)	5.77	0.04 (0.70%)	3.28 - 26.81	2,189,262	1,263,553	2,263
Esperion Therapeutics Q1 2022 Earnings Preview [5/2/2022 11:32 AM] Esperion Therapeutics GAAP EPS of -$0.93 beats by $0.11, revenue of $18.83M beats by $3.42M [5/3/2022 7:13 AM] Esperion stock rises as Q1 revenue soars 136% Y/Y [5/3/2022 12:04 PM] Drug/Biotech Stocks Q1 Earnings Due on May 3: PFE, BIIB & More [May-02-22 03:55PM] Esperion Announces Publication of CLEAR Harmony Open-Label Extension Study Data for Bempedoic Acid in the American Journal of Cardiology [May-02-22 08:00AM] Esperion Reports First Quarter 2022 Financial Results and Provides Company Update [May-03-22 07:00AM] Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates [May-03-22 08:25AM] Esperion Therapeutics (ESPR) Q1 2022 Earnings Call Transcript [May-03-22 02:00PM]
22-02-2022	PM	7:00 AM ET (Feb 22)	ESPR	Esperion Therapeutics, Inc.	238.12	-1.77	-2.32	-3.89	Esperion Therapeutics GAAP EPS of -$1.77 beats by $0.52, revenue of $15.4M beats by $0.92M [2/22/2022 7:02 AM]	4.34	0.51 (13.15%)	3.95	0.11 (2.86%)	3.28 - 32.00	1,967,886	1,140,000	3,152
Esperion Therapeutics GAAP EPS of -$1.77 beats by $0.52, revenue of $15.4M beats by $0.92M [2/22/2022 7:02 AM] Esperion stock rises 12% as FY21 net product sales soar 209% Y/Y [2/22/2022 11:13 AM] Esperion Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update [Feb-22-22 07:00AM] Esperion Therapeutics (ESPR) Reports Q4 Loss, Tops Revenue Estimates [Feb-22-22 08:15AM] Esperion Therapeutics (ESPR) Q4 2021 Earnings Call Transcript [Feb-22-22 02:00PM]
02-11-2021	PM	7:00 AM ET (Nov 2)	ESPR	Esperion Therapeutics, Inc.	237.18	-2.62	-2.86	-3.07	Esperion Therapeutics EPS beats by $0.22, beats on revenue [11/2/2021 7:16 AM]	10.31	0.20 (1.98%)	10.31	0.0 (0.00%)	7.73 - 39.49	1,283,697	1,350,000	2,122
Esperion Therapeutics Q3 2021 Earnings Preview [11/1/2021 12:47 PM] Esperion Therapeutics EPS beats by $0.22, beats on revenue [11/2/2021 7:16 AM] Esperion Q3 2021 earnings beat helped by rising sales of cholesterol-lowering drugs [11/2/2021 10:19 AM] Esperion to Present Key Science at the American Heart Association Scientific Sessions 2021 [Nov-01-21 04:01PM] Esperion Announces the Appointment of Seth H.Z. Fischer to its Board of Directors [Nov-01-21 07:00AM] Esperion Reports Third Quarter 2021 Financial Results and Provides Company Update [Nov-02-21 07:00AM] Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates [Nov-02-21 08:45AM] Esperion (ESPR) Beats on Q3 Earnings, Lowers Expense Guidance [Nov-02-21 10:57AM] Esperion Therapeutics, inc (ESPR) Q3 2021 Earnings Call Transcript [Nov-02-21 04:30PM]
03-08-2021	PM	7:00 AM ET (Aug 3)	ESPR	Esperion Therapeutics, Inc.	433.88	-1.67	-1.83	4.32	Esperion Therapeutics EPS beats by $0.19, misses on revenue [8/3/2021 7:08 AM]	14.27	-0.72 (-4.84%)	14.97	-0.02 (-0.13%)	13.74 - 41.48	1,285,770	740,000	2,349
Esperion Therapeutics Q2 2021 Earnings Preview [8/2/2021 12:47 PM] Esperion Therapeutics EPS beats by $0.19, misses on revenue [8/3/2021 7:08 AM] 10 Best High Short Interest Stocks to Buy Now [Aug-02-21 01:07PM] ESPERION Reports Second Quarter 2021 Financial Results and Provides Company Update [Aug-03-21 07:00AM] Esperion Therapeutics (ESPR) Reports Q2 Loss, Misses Revenue Estimates [Aug-03-21 08:55AM] Esperion Therapeutics, inc (ESPR) Q2 2021 Earnings Call Transcript [Aug-03-21 08:00PM]
04-05-2021	AH	4:10 PM ET (May 4)	ESPR	Esperion Therapeutics, Inc.	774.57	-3.50	-2.08	-2.84	Esperion Therapeutics EPS misses by $0.77, misses on revenue; provides outlook [5/4/2021 4:07 PM]	20.01	-5.58 (-21.81%)	18.36	-7.23 (-28.25%)	18.01 - 53.73	5,132,823	470,000	753,134
Esperion Therapeutics EPS misses by $0.77, misses on revenue; provides outlook [5/4/2021 4:07 PM] Esperion sinks after Stifel downgrade, Community Health adds another bull; in today’s healthcare analyst action [5/5/2021 9:01 AM] Esperion’s bull case is off the table: Stifel [5/5/2021 3:53 PM] Esperion Therapeutics, Inc. to Host Earnings Call [May-04-21 02:30PM] ESPERION Reports First Quarter 2021 Financial Results and Provides Company Update [May-04-21 04:01PM] Esperion Therapeutics (ESPR) Reports Q1 Loss, Misses Revenue Estimates [May-04-21 05:55PM] Esperion Therapeutics Inc (ESPR) Q1 2021 Earnings Call Transcript [May-04-21 09:00PM] Esperion (ESPR) Q1 Earnings Miss, Lower Drug Price Hits Sales [May-05-21 10:28AM] Why Esperion Therapeutics Plummeted Nearly 22% Today [May-05-21 06:30PM]
23-02-2021	AH	4:00 PM ET (Feb 23)	ESPR	Esperion Therapeutics, Inc.	764.65	-3.89	-3.76	-2.26	Esperion Therapeutics EPS misses by $0.16, misses on revenue [2/23/2021 4:10 PM]	28.62	0.74 (2.65%)	29.26	1.38 (4.95%)	23.90 - 67.59	673,874	835,876	1,148
Esperion Therapeutics EPS misses by $0.16, misses on revenue [2/23/2021 4:10 PM] ESPERION Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update [Feb-23-21 04:01PM] Esperion Therapeutics, Inc. to Host Earnings Call [Feb-23-21 02:30PM]
02-11-2020	AH	4:00 PM ET (Nov 2)	ESPR	Esperion Therapeutics, Inc.	872.61	-3.07	-3.52	-2.52	Esperion Therapeutics EPS beats by $0.49, misses on revenue [11/2/2020 4:20 PM]	24.23	-4.76 (-16.41%)	25.67	-3.32 (-11.45%)	23.90 - 76.98	4,216,296	528,950	88,856

10-08-2020	AH	4:05 PM ET (Aug 10)	ESPR	Esperion Therapeutics, Inc.	1,070	4.32	2.13	-2.01	Esperion Therapeutics EPS beats by $2.09, beats on revenue [8/10/2020 4:13 PM]	34.67	-2.33 (-6.30%)	36.10	-0.90 (-2.43%)	24.82 - 76.98	1,207,000	704,273	14,578

06-05-2020	AH		ESPR	Esperion Therapeutics, Inc.	1,080	-2.84	-3.14	3.07		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0